GR1008804B - Συνθεσεις για ιατρικη χρηση οι οποιες περιλαμβανουν υαλουρονικο οξυ ή αλατα αυτου, αμινοξεα, βιταμινες, ανοργανα αλατα και αλλα συστατικα - Google Patents
Συνθεσεις για ιατρικη χρηση οι οποιες περιλαμβανουν υαλουρονικο οξυ ή αλατα αυτου, αμινοξεα, βιταμινες, ανοργανα αλατα και αλλα συστατικαInfo
- Publication number
- GR1008804B GR1008804B GR20150100259A GR20150100259A GR1008804B GR 1008804 B GR1008804 B GR 1008804B GR 20150100259 A GR20150100259 A GR 20150100259A GR 20150100259 A GR20150100259 A GR 20150100259A GR 1008804 B GR1008804 B GR 1008804B
- Authority
- GR
- Greece
- Prior art keywords
- salts
- vitamins
- components
- amino acids
- hyaluronic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Abstract
Η εφεύρεση αφορά μία σύνθεση, η οποία περιέχει υαλουρονικό οξύ ή φαρμακευτικά αποδεκτά άλατα αυτού, και μίγμα πολλαπλασιασμού κυττάρων, το οποίο περιέχει αμινοξέα, βιταμίνες, ανόργανα άλατα και άλλα συστατικά.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20150100259A GR1008804B (el) | 2015-06-08 | 2015-06-08 | Συνθεσεις για ιατρικη χρηση οι οποιες περιλαμβανουν υαλουρονικο οξυ ή αλατα αυτου, αμινοξεα, βιταμινες, ανοργανα αλατα και αλλα συστατικα |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20150100259A GR1008804B (el) | 2015-06-08 | 2015-06-08 | Συνθεσεις για ιατρικη χρηση οι οποιες περιλαμβανουν υαλουρονικο οξυ ή αλατα αυτου, αμινοξεα, βιταμινες, ανοργανα αλατα και αλλα συστατικα |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1008804B true GR1008804B (el) | 2016-07-01 |
Family
ID=56990142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20150100259A GR1008804B (el) | 2015-06-08 | 2015-06-08 | Συνθεσεις για ιατρικη χρηση οι οποιες περιλαμβανουν υαλουρονικο οξυ ή αλατα αυτου, αμινοξεα, βιταμινες, ανοργανα αλατα και αλλα συστατικα |
Country Status (1)
Country | Link |
---|---|
GR (1) | GR1008804B (el) |
-
2015
- 2015-06-08 GR GR20150100259A patent/GR1008804B/el active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017500281A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
MX2018007704A (es) | Composicion farmaceutica que comprende lenalidomida amorfa y un antioxidante. | |
MX2022001292A (es) | Composiciones enriquecidas estereoquimicamente para administracion de acidos nucleicos. | |
MY187047A (en) | Selective pyy compounds and uses thereof | |
MX2016016593A (es) | Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos. | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
MX2017014035A (es) | Formas solidas novedosas. | |
PH12017501539A1 (en) | Disacetoxytubulysin h and analogs thereof | |
MX2016011105A (es) | Inhibidores de monoacilglicerol aciltransferasa 2 (mgat2) de dihidropiridinona para usarse en el tratamiento de trastornos metabolicos. | |
MX2021008432A (es) | Composiciones farmaceuticas y usos dirigidos a los trastornos del almacenamiento lisosomal. | |
MA39765A (fr) | Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation | |
EA032927B1 (ru) | Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора | |
BR112017012406A2 (pt) | formulação com relação fixa de insulina glargina/lixisenatida | |
MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
WO2014033526A9 (en) | Pharmaceutical compositions of etoricoxib | |
MX2017016231A (es) | Compuestos de aminobencisoxazol como agonistas de receptores a7-nicotínicos de acetilcolina. | |
MX2020012989A (es) | Agente terapeutico para la fibrosis. | |
MY192813A (en) | Aqueous formulation comprising paracetamol and ibuprofen | |
MX2017009849A (es) | Composiciones de profármaco de monometilfumarato. | |
MX2017010666A (es) | Acido (2r,4r)-5-(5'-cloro-2'-fluorobifenil-4-il)-2-hidroxi-4-[(5-m etiloxazol-2-carbonil)amino]pentanoico. | |
PH12018500358A1 (en) | Compounds for use in an antibacterial applications | |
MX2018014129A (es) | Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato. | |
EA201691792A1 (ru) | Фармацевтические составы на основе вилдаглиптина |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted |
Effective date: 20160906 |